Protocol 2: Intermediate approach (experienced researchers) Goal: Multi-target immune modulation with anti-inflammatory support Components: Thymosin alpha-1: 1.6 mg subcutaneously, three times weekly KPV: 200-500 mcg subcutaneously, once daily BPC-157: 250 mcg subcutaneously, twice daily Selank: 250-500 mcg intranasally, once daily Schedule: Monday, Wednesday, Friday: Thymosin alpha-1 Daily AM: KPV + BPC-157 Daily PM: BPC-157 Daily: Selank nasal spray (morning or midday) Duration: 12 weeks on, 4 weeks off Monitoring: Baseline labs, repeat every 4 weeks
Temporary pain or redness at the injection site is also reported in some people
The peptide will not dissolve You added the water, waited 20 minutes, gently rolled the vial, and there are still particles or chunks of undissolved powder
B12 shots can help restore healthy red blood cell production, alleviating the fatigue associated with anemia
Raman spectra of polyLlysines
The objective is to support higher quality study planning, clearer reporting, and improved reproducibility for laboratories working in NNMT biology, one carbon biochemistry, NAD+ pathway studies, and systems level metabolism
